Atherosclerosis, thrombosis and inflammation: A problem of linkage

Fibrinolysis and Proteolysis

Volumn 11, Issue SUPPL. 1, 1997, Pages 137-141

  Tracy, R P ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; CYTOKINE; FIBRINOGEN; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ACUTE PHASE RESPONSE; ATHEROSCLEROSIS; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DISEASE MARKER; FIBRINOLYSIS; HUMAN; INFLAMMATION; PRIORITY JOURNAL; RISK FACTOR; SMOKING; THROMBOSIS;

EID: 0030709426     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(97)80040-9     Document Type: Conference Paper

References (51)

1. Meade T W, Chakrabarti R, Haines A P, North W R S, Stirling Y, Thompson S G. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1980; i: 1050-4.
2. Meade T W, Brozovic M, Chakrabarti R R, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; ii: 533-7.
3. Kannel W B, Wolf P A, Castelli W P, D'Agostino R B. Fibrinogen and risk of cardiovascular disease: the Framingham study. JAMA 1987; 258: 1183-6.
4. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Eng J Med 1984; 311: 501-5.
5. Stone M C, Thorp J M. Plasma fibrinogen - a major coronary risk factor. J R Coll Gen Pract 1985; 35: 565-9.
6. Yarnell J W G, Baker I A, Sweetnam P M, et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. Circulation 1991; 83: 836-44.
7. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk: Results from the PROCAM study in healthy men. Arterioscler Thromb 1994; 14: 54-9.
8. Folsom A R, Wu K K, Rosamond W D, Sharrett A R, Chambless L E. Hemostatic factors and incidence of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) study. Circulation 1996; 93: 622 (abstract).
9. Tracy R P, Bovill E G, Yanez D, et al. Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly: results from the Cardiovascular Health Study. Arterioscler Thromb Vase Biol 1995; 15: 1269-79.
10. Cushman M, Yanez D, Psaty B M, et al. Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: the Cardiovascular Health Study. Amer J Epidemiol 1996; 143: 665-76.
11. Bruckert E, Carvalho de Sousa J, Giral P, et al. Interrelationship of plasma triglyceride and coagulant factor VII levels in normotriglyceridemic hypercholesterolemia. Atherosclerosis 1989; 75: 129-34.
12. Carvalho de Sousa J C, Azevedo J, Soria C, et al. Factor VII hyperactivity in acute myocardial thrombosis. A relation to the coagulation activation. Thrombos Res 1988; 51: 165-73.
13. Carvalho de Sousa J, Bruckert E, Giral P, et al. Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidemia: a clinical and laboratory study. Haemostasis 1989; 19: 83-90.
14. Dalaker K, Hjermann I, Prydz H. A novel form of factor VII in plasma from men at risk for cardiovascular disease. Br J Haematol 1985; 61: 315-22.
15. Dalaker K, Smith P, Arnesen H, Prydz H. Factor VII-phospholipid complex in male survivors of acute myocardial infarction. Acta Med Scand 1987; 222: 111-6.
16. Huffman C, Shah A, Sodums M, Hultin M B. Factor VII activity state in coronary artery disease. J Lab Clin Med 1988; 111: 475-81.
17. Hoffman C J, Miller R H, Lawson W E, Hultin M B. Elevation of factor VII activity and mass in young adults at risk of ischaemic heart disease. JACC 1989; 14: 941-6.
18. Miller G J, Walter S J, Stirling Y, Thompson S G, Esnouf M O, Meade T W. Assay of factor VII activity by two techniques: evidence for increased conversion of VII to Vila in hyperlipidemia, with possible implications for ischaemic heart disease. Br J Haematol 1985; 59: 249-58.
19. Miller G J, Martin J C, Webster J, et al. Association between dietary fat intake and plasma factor VII coagulant activity - a predictor of cardiovascular mortality. Athersclerosis 1986; 60: 269-77.
20. Orlando M, Leri O, Macioce G, Mattia G, Fern G M. Factor VII in subjects at risk for thromboembolism: activation or increased synthesis? Haemostasis 1987; 17: 340-3.
21. Tracy R P, Arnold A, W H Ettinger, L P Freid, E Meilahn, P J Savage. Coagulation factor VIII is associated with incident cardiovascular disease and death in the elderly: the Cardiovascular Health Study. Circulation 1996; 94: 1-457 (Abstract).
22. Hamsten A, Wiman B, de Faire U, Blomback M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Eng J Med 1985; 313: 1557-63.
23. Hamsten A, de Faire U, Walldius G, et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; ii: 3-9.
24. Tracy R P, Bovill E G. Hemostasis and risk of ischemic disease: epidemiologic evidence with emphasis on the elderly. In: R Califf, D Mark, G Wagner (eds.) Acute Coronary Care in the Thrombolytic Era. 2nd edn. MO: Mosby-Year Book, Inc., St. Louis 1995: 27-43.
25. Tracy R P, Bovill E G. Thrombosis and cardiovascular risk in the elderly. Arch Path Lab Med 1992; 116: 1307-12.
26. Fuster V, Badimon L, Badimon J J, Chesebro J H. The pathogenesis of coronary artery disease and the acute coronary syndromes: Part 1. N Eng J Med 1992; 326: 242-50.
27. Fuster V, Stein B, Ambrose J A, Badimon L, Badimon J J, Chesebro J H. Atherosclerotic plaque rupture and thrombosis: evolving concepts. Circulation 1990; 82: 1147-1159.
28. Kuller L H, Shemanski L, Psaty B M, et al. Subclinical disease as an independent risk factor for cardiovascular disease. Circulation 1995; 92: 720-6.
29. Berliner J A, Navab M, Fogelman A M, et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995; 91: 2488-96.
30. Buja L, Willerson J. Role of inflammation in coronary plaque disruption. Circulation 1994; 89: 503-5.
31. Entman M L, Ballantyne C M. Inflammation in acute coronary syndromes. Circulation 1993; 88: 800-3.
32. Esmon C T, Taylor F B, Snow T R. Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost 1991; 66: 160-5.
33. Jang I K, Lassila R, Fuster V. Atherogenesis and inflammation. Eur Heart J 1993; 14 (suppl K): 2-6.
34. Marcus A J. Thrombosis and inflammation as multicellular processes: pathophysiologic significance of transcellular metabolism. Blood 1990; 76: 1903-7.
35. Munro J M, Cotran R S. Biology of Disease: the pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Investigation 1988; 58: 249-61.
36. Baumann H, Isseroff H, Latimer J J, Jabreis G P. Phorbol ester modulates Interleukin-6 and Interleukin-1-regulated expression of acute phase plasma proteins in hepatoma cells. J Biol Chem 1988; 263: 1530-4.
37. Ernst E, Resch K L. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature. Ann Intern Med 1993; 118: 956-63.
38. Kronmal R A, Cain K C, Ye Z, Omenn G S. Total serum cholesterol levels and mortality risk as a function of age. Arch Intern Med 1993; 153: 1065-73.
39. Ettinger W H, Harris T, Verdery R B, Tracy R P, Kouba E. Evidence for inflammation as a cause of hypocholesterolemia in older people. JAGS 1995; 43: 264-6.
40. Iribarren C, Reed D M, Chen R, Yano K, Dwyer J H. Low serum cholesterol and mortality: which is the cause and which is the effect? Circulation 1995; 92: 2396-403.
41. Liuzzo G, Biasucci L M, Gallimore J R, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417-24.
42. Thompson S G, Kienast J, Pyke S D M, Haverkate F, van de Loo J C W. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332: 635-41.
43. Kuller L H, Tracy R P, Shaten J, Meilahn E, for the MRFIT Research Group. Relationship of C-Reactive Protein and Coronary Heart Disease in the MRFIT nested case-control study. Am J Epidemiol 1996; 144: 537-47.
44. Tracy R P, Kuller L H, Psaty B M, Cushman M, Meilahn E N, Smith N. C-Reactive Protein and incidence of cardiovascular disease in older women: the Rural Health Promotion Project and the Cardiovascular Health Study. Circulation 1996; 93: 622 (Abstract).
45. Patel P, Mendall M A, Carrington D, et al. Association of Heliobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995; 311: 711-4.
46. Salonen J T, Salonen R, Korpela H, Suntioinen S, Tuomilehto J. Serum copper and the risk of acute myocardial infarction: a prospective population study in men in eastern Finland. Amer J Epidemiol 1991; 134: 268-76.
47. Salonen J T, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992; 86: 803-11.
48. Ridker P M, Vaughan D E, Stampfer M J, Manson J E, Hennekens C H. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993; 341: 1165-8.
49. Tracy R P, Lemaitre R N, Psaty B M, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vase Biol (in press)
50. Kuller L H, Eichner J E, Orchard T J, et al. The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. Am J Epidemiol 1991; 134: 1266-77.
51. Schwertner H, Jackson W, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 1994; 40: 18-23.